Cite

HARVARD Citation

    Gadgeel, S. et al. (n.d.). 3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test. European journal of cancer. pp. S628-. [Online]. 
  
Back to record